Lichen International Ltd Enters Securities Purchase Agreements
Ticker: LICN · Form: 6-K · Filed: Sep 19, 2025 · CIK: 1876766
| Field | Detail |
|---|---|
| Company | Lichen International LTD (LICN) |
| Form Type | 6-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.008, $1.20, $18,600,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financing, securities-purchase-agreement
TL;DR
LICHEN just signed new deals with investors on Sept 15, 2025.
AI Summary
On September 15, 2025, Lichen International Limited entered into securities purchase agreements with certain investors. The company, formerly known as Lichen China Ltd, is a Cayman Islands exempted company and operates in the management consulting services sector.
Why It Matters
This filing indicates potential new investment or financing for Lichen International Limited, which could impact its future operations and growth.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a securities purchase agreement, with no immediate negative financial implications mentioned.
Key Players & Entities
- Lichen International Limited (company) — Registrant
- Lichen China Ltd (company) — Former company name
- September 15, 2025 (date) — Date of securities purchase agreements
FAQ
What is the nature of the securities purchase agreements entered into by Lichen International Limited?
The filing states that on September 15, 2025, Lichen International Limited entered into securities purchase agreements with certain investors.
When did Lichen International Limited change its name from Lichen China Ltd?
The date of the name change from Lichen China Ltd to Lichen International Ltd was August 3, 2021.
What is the primary business of Lichen International Limited?
Lichen International Limited is classified under SERVICES-MANAGEMENT CONSULTING SERVICES with SIC code 8742.
Where is Lichen International Limited's principal executive office located?
The principal executive office is located at 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013.
Does Lichen International Limited file annual reports under Form 20-F or Form 40-F?
Lichen International Limited indicates it files annual reports under cover of Form 20-F.
Filing Stats: 432 words · 2 min read · ~1 pages · Grade level 14 · Accepted 2025-09-19 16:15:17
Key Financial Figures
- $0.008 — the “Purchased Shares), par value $0.008 per share, of the Company (the “C
- $1.20 — quo;Class A Ordinary Shares”), at $1.20 per share for a total purchase price of
- $18,600,000 — per share for a total purchase price of $18,600,000 (the “Purchase Price”), pay
Filing Documents
- licn6k091725.htm (6-K) — 12KB
- lichenex10-1.htm (EX-10.1) — 125KB
- 0001185185-25-001236.txt ( ) — 138KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month ended September 2025 Commission File No. 001-41493 LICHEN INTERNATIONAL LIMITED (Translation of registrant’s name into English) 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F Form 40-F On September 15, 2025, Lichen International Limited, a Cayman Islands exempted company (the “Company”), entered into securities purchase agreements (the “Securities Purchase Agreements”) with certain investors (the “Investors”) relating to the issuance and sale of 15,500,000 Class A ordinary shares (the “Purchased Shares), par value $0.008 per share, of the Company (the “Class A Ordinary Shares”), at $1.20 per share for a total purchase price of $18,600,000 (the “Purchase Price”), payable in cash. The Company received the Purchase Price and issued the Purchased Shares on September 19, 2025 (the “Closing” or “Closing Date”). The Purchased Shares were issued in a private placement exempt from the registration requirements of the U.S. Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof, Regulation D promulgated thereunder and/or Regulation S promulgated thereunder. The foregoing summary of the Securities Purchase Agreements does not purport to be complete and are subject to, and qualified in their entirety by, such documents filed as Exhibit 10.1 hereto and incorporated by reference herein. This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. This report on Form 6-K is incorporated by reference into the Company’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on October 18, 2023 (Registration No. 333-275086) and the Company’s Registration Statement on Form F-3 filed with the Securities and Exchange Commission on February 21, 2024 (Registration No. 333-277230). 1 EXHIBIT INDEX Exhibit No. Description 10.1 Form of Securities Purchase Agreement 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Lichen China Limited Date: September 19, 2025 By: /s/ Ya Li Name: Ya Li Title Chief Executive Officer 3